Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hoth Therapeutics Inc HOTH

Healthcare Biotechnology
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s... see more

Bullboard (NDAQ:HOTH)

View:
Prev 1 2 3 Next
Comment by Iseneschalon Mar 19, 2024 8:29am

RE:Hoth ...early a.m runner on NR $1.75

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ 2024-03-19 05:21 ET - News Release NEW YORK March 19, 2024  ...more  
20
Discussion
Post by 7Twiggyon Jan 18, 2024 2:11pm

Makes me wonder

The way I understand the news release, this  is the second approval for another group of patients with more serious conditions than the first. You think there must be something positive going on ...more  
45
Post by 7Twiggyon Jan 18, 2024 12:49pm

One third of the float traded

You must be talking about a different stock.  This one has a 4.5 million float and has traded 1.5 million shares or about one third of the shares out.  That is one heck of a lot of volume ...more  
52
Post by Iseneschalon Jan 18, 2024 10:39am

HOTH....sold

Vols aren't good enough Thanks for the Lunch money
43
Post by Iseneschalon Jan 18, 2024 10:34am

HOTH....moving up slowly ...she got....

Wonky eyeball Gonna be good....on watch with a nice position
38
Post by Iseneschalon Jan 18, 2024 8:34am

HOTH.....NR this a.m....LFG!

  Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients   2024-01-18 05:20 PT - News Release   Patients will ...more  
38
Post by 7Twiggyon Dec 21, 2023 11:35am

Tax loss selling

Lots of risks, but also lots of potential.  Added a little more.  Hoping for the home run.
41
Prev 1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities